Literature DB >> 17456154

Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays.

J K Cooper1, K Ladhani, P D Minor.   

Abstract

BACKGROUND AND OBJECTIVES: A standard panel of materials is needed for the evaluation of assays being developed for the diagnosis of variant Creutzfeldt-Jakob disease.
MATERIALS AND METHODS: Tissues from human and animals incubating transmissible spongiform encephalopathy disease have been prepared, aliquoted and where possible characterized by in vitro methods.
RESULTS: A standardized preparation of materials has been generated.
CONCLUSIONS: Large-scale preparations of tissues and blood fractions can be used to directly compare the sensitivities of assays using different formats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456154     DOI: 10.1111/j.1423-0410.2007.00904.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

1.  The octarepeat region of the prion protein is conformationally altered in PrP(Sc).

Authors:  Alice Y Yam; Carol Man Gao; Xuemei Wang; Ping Wu; David Peretz
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

2.  Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice.

Authors:  Danielle Padilla; Vincent Béringue; Juan Carlos Espinosa; Olivier Andreoletti; Emilie Jaumain; Fabienne Reine; Laetitia Herzog; Alfonso Gutierrez-Adan; Belen Pintado; Hubert Laude; Juan Maria Torres
Journal:  PLoS Pathog       Date:  2011-03-17       Impact factor: 6.823

3.  Protective Effect of Val129-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease.

Authors:  Natalia Fernández-Borges; Juan Carlos Espinosa; Alba Marín-Moreno; Patricia Aguilar-Calvo; Emmanuel A Asante; Tetsuyuki Kitamoto; Shirou Mohri; Olivier Andréoletti; Juan María Torres
Journal:  Emerg Infect Dis       Date:  2017-09       Impact factor: 6.883

4.  No major change in vCJD agent strain after secondary transmission via blood transfusion.

Authors:  Matthew T Bishop; Diane L Ritchie; Robert G Will; James W Ironside; Mark W Head; Val Thomson; Moira Bruce; Jean C Manson
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.